Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Adam Wolfe

Concepts (168)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
7
2024
206
4.180
Why?
Radiation Tolerance
6
2024
84
2.950
Why?
Carcinoma, Pancreatic Ductal
4
2024
31
2.660
Why?
MicroRNAs
3
2024
344
1.180
Why?
Inflammatory Breast Neoplasms
3
2017
4
1.150
Why?
Cell Line, Tumor
12
2024
1398
1.130
Why?
Proto-Oncogene Proteins B-raf
3
2024
80
1.100
Why?
Xenograft Model Antitumor Assays
5
2024
212
1.080
Why?
Neoplastic Stem Cells
3
2016
98
1.030
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2020
1000
1.020
Why?
Lipoproteins, HDL
2
2016
18
1.000
Why?
Tumor Burden
3
2020
130
0.990
Why?
Thyroid Neoplasms
2
2024
112
0.950
Why?
CDC2 Protein Kinase
1
2024
16
0.940
Why?
Gene Expression Regulation, Neoplastic
3
2024
833
0.900
Why?
Proto-Oncogene Proteins p21(ras)
1
2024
67
0.890
Why?
Signal Transduction
4
2024
1624
0.840
Why?
DNA-Binding Proteins
1
2024
418
0.740
Why?
Neoadjuvant Therapy
2
2020
120
0.680
Why?
Neutrophils
1
2021
145
0.670
Why?
Fellowships and Scholarships
1
2020
120
0.650
Why?
Mutation
2
2024
1280
0.650
Why?
Physicians
1
2022
232
0.640
Why?
Cell Movement
2
2016
247
0.620
Why?
Melanoma
1
2021
280
0.600
Why?
Forkhead Transcription Factors
2
2015
110
0.600
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2016
138
0.580
Why?
Macrophages
2
2017
364
0.560
Why?
Paracrine Communication
1
2016
12
0.550
Why?
Breast Neoplasms
2
2016
1201
0.540
Why?
Simvastatin
1
2015
29
0.500
Why?
Interleukin-6
1
2016
261
0.490
Why?
Lipoproteins, VLDL
1
2015
9
0.490
Why?
Internship and Residency
1
2020
447
0.490
Why?
Humans
23
2024
50503
0.470
Why?
Mice, Nude
4
2024
248
0.450
Why?
Mice, SCID
3
2020
178
0.430
Why?
Animals
9
2024
13124
0.430
Why?
Mice
7
2024
5687
0.420
Why?
Inflammation
1
2016
610
0.400
Why?
Neoplasm Recurrence, Local
3
2021
629
0.370
Why?
Antineoplastic Agents
2
2016
1172
0.360
Why?
Albumins
2
2020
31
0.350
Why?
Deoxycytidine
2
2020
30
0.350
Why?
Chemotherapy, Adjuvant
2
2020
121
0.340
Why?
Paclitaxel
2
2020
84
0.340
Why?
Proportional Hazards Models
2
2021
415
0.330
Why?
Female
13
2022
27081
0.290
Why?
Aged, 80 and over
4
2021
3226
0.260
Why?
Thiazoles
2
2024
53
0.260
Why?
Cell Proliferation
3
2020
985
0.250
Why?
Retrospective Studies
3
2022
6263
0.240
Why?
Middle Aged
6
2021
12611
0.240
Why?
Quinolines
1
2024
41
0.230
Why?
Caveolae
1
2024
6
0.230
Why?
ras Proteins
1
2024
64
0.220
Why?
Endocytosis
1
2024
55
0.220
Why?
Transfection
1
2024
356
0.210
Why?
Hospitals, Community
1
2022
19
0.200
Why?
Career Mobility
1
2022
28
0.200
Why?
Arm
1
2022
47
0.200
Why?
Mentors
1
2022
55
0.200
Why?
DNA Damage
1
2024
301
0.200
Why?
Edema
1
2022
69
0.190
Why?
Neoplasm Staging
2
2021
746
0.190
Why?
Faculty, Medical
1
2022
92
0.190
Why?
Cell Cycle
2
2020
226
0.190
Why?
Caveolin 1
1
2020
21
0.180
Why?
Phosphorylation
3
2017
525
0.180
Why?
Lymphatic Metastasis
1
2021
222
0.180
Why?
Mice, Inbred NOD
1
2020
91
0.180
Why?
Faculty
1
2020
72
0.180
Why?
Leucovorin
1
2020
20
0.170
Why?
Radiotherapy, Adjuvant
1
2020
64
0.170
Why?
Fluorouracil
1
2020
58
0.170
Why?
Lymphocytes
1
2021
149
0.170
Why?
Spleen
1
2021
169
0.170
Why?
Male
7
2021
25907
0.170
Why?
Radiation Dosage
1
2021
162
0.170
Why?
Coculture Techniques
2
2017
142
0.170
Why?
Drug Administration Schedule
1
2020
370
0.170
Why?
Linear Models
1
2020
279
0.160
Why?
Survival Rate
3
2019
909
0.160
Why?
Child
2
2022
6906
0.160
Why?
Carcinoma, Non-Small-Cell Lung
1
2021
154
0.160
Why?
Radiation-Sensitizing Agents
1
2019
51
0.160
Why?
DNA Breaks, Double-Stranded
1
2019
65
0.160
Why?
Kaplan-Meier Estimate
1
2020
464
0.160
Why?
Aged
3
2021
9741
0.150
Why?
Tumor Microenvironment
2
2017
222
0.150
Why?
Interleukin-13
1
2017
14
0.150
Why?
STAT6 Transcription Factor
1
2017
7
0.150
Why?
DNA Repair
2
2019
188
0.150
Why?
Cell Polarity
1
2017
17
0.150
Why?
Adult
4
2021
13577
0.150
Why?
Interleukin-4
1
2017
42
0.150
Why?
Mice, Knockout
1
2020
844
0.150
Why?
Protein Kinase C
1
2017
71
0.140
Why?
Treatment Outcome
2
2020
5283
0.140
Why?
Cell Survival
2
2019
589
0.140
Why?
Proto-Oncogene Proteins c-akt
2
2015
156
0.140
Why?
Macrophage Colony-Stimulating Factor
1
2016
10
0.140
Why?
STAT3 Transcription Factor
1
2016
77
0.130
Why?
Adenocarcinoma
1
2020
397
0.130
Why?
Cell Dedifferentiation
1
2016
9
0.130
Why?
Head and Neck Neoplasms
1
2019
287
0.130
Why?
Neoplasm Invasiveness
1
2016
269
0.130
Why?
Histone Deacetylase Inhibitors
1
2016
56
0.130
Why?
Prognosis
1
2021
1978
0.130
Why?
Tumor Stem Cell Assay
1
2015
17
0.120
Why?
Carcinoma, Ductal, Breast
1
2016
91
0.120
Why?
Anticholesteremic Agents
1
2015
27
0.120
Why?
Lung Neoplasms
1
2021
601
0.120
Why?
Neoplasm Metastasis
1
2015
232
0.120
Why?
Dyslipidemias
1
2015
37
0.120
Why?
Intercellular Signaling Peptides and Proteins
1
2015
102
0.120
Why?
Cholesterol
1
2015
150
0.120
Why?
Regression Analysis
1
2015
382
0.110
Why?
Receptor, IGF Type 1
1
2012
20
0.100
Why?
Receptor, Insulin
1
2012
37
0.100
Why?
src-Family Kinases
1
2012
51
0.100
Why?
Brain Neoplasms
1
2016
291
0.100
Why?
Bone Diseases
1
2012
96
0.100
Why?
Time Factors
1
2016
2935
0.090
Why?
Prostatic Neoplasms
1
2012
384
0.080
Why?
Apoptosis
1
2012
1097
0.070
Why?
Protein Kinase Inhibitors
2
2019
204
0.060
Why?
Neoplasm Grading
1
2020
122
0.040
Why?
Carboplatin
1
2019
54
0.040
Why?
Chemoradiotherapy
1
2019
42
0.040
Why?
Papillomaviridae
1
2019
103
0.040
Why?
Immunotherapy
1
2021
235
0.040
Why?
Diagnosis, Differential
1
2022
1033
0.040
Why?
MAP Kinase Signaling System
1
2019
117
0.040
Why?
Radiotherapy
1
2019
125
0.040
Why?
Chemokine CCL22
1
2017
2
0.040
Why?
Phosphopeptides
1
2017
6
0.040
Why?
src Homology Domains
1
2017
9
0.040
Why?
Mannose-Binding Lectins
1
2017
7
0.040
Why?
Biomimetic Materials
1
2017
10
0.040
Why?
Enzyme Induction
1
2017
79
0.040
Why?
Lectins, C-Type
1
2017
30
0.040
Why?
Fibronectins
1
2017
38
0.040
Why?
Molecular Mimicry
1
2017
38
0.040
Why?
Cisplatin
1
2019
286
0.040
Why?
Genetic Markers
1
2017
104
0.040
Why?
Papillomavirus Infections
1
2019
168
0.040
Why?
RNA, Small Interfering
1
2017
208
0.030
Why?
Receptors, Cell Surface
1
2017
116
0.030
Why?
Randomized Controlled Trials as Topic
1
2019
573
0.030
Why?
Pentose Phosphate Pathway
1
2016
2
0.030
Why?
Glucosephosphate Dehydrogenase
1
2016
6
0.030
Why?
Gene Knockdown Techniques
1
2016
105
0.030
Why?
Receptor, erbB-2
1
2016
75
0.030
Why?
Cadherins
1
2016
63
0.030
Why?
Disease-Free Survival
1
2016
444
0.030
Why?
Phenotype
1
2017
739
0.030
Why?
Infant
1
2022
3628
0.030
Why?
Predictive Value of Tests
1
2016
930
0.030
Why?
Immunoprecipitation
1
2012
59
0.030
Why?
Triazines
1
2012
24
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
234
0.020
Why?
Tumor Cells, Cultured
1
2012
457
0.020
Why?
Pyrazoles
1
2012
111
0.020
Why?
Drug Therapy, Combination
1
2012
384
0.020
Why?
Blotting, Western
1
2012
578
0.020
Why?
Pyrimidines
1
2012
191
0.020
Why?
Disease Models, Animal
1
2016
1436
0.020
Why?
Wolfe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description